|1.||Uchibori, Takehiro: 3 articles (01/2015 - 04/2005)|
|2.||Sasamori, Jun: 3 articles (01/2015 - 04/2006)|
|3.||Tanonaka, Kouichi: 2 articles (01/2015 - 02/2011)|
|4.||Takeo, Satoshi: 2 articles (02/2011 - 04/2006)|
|5.||Aihara, Kazuyuki: 2 articles (02/2011 - 04/2006)|
|6.||Kogi, Kentaro: 2 articles (04/2006 - 04/2005)|
|7.||Marunouchi, Tetsuro: 1 article (01/2015)|
|8.||Manome, Yoichi: 1 article (01/2015)|
|9.||Abe, Yohei: 1 article (01/2015)|
|10.||Takahashi, Atsuo: 1 article (02/2011)|
01/01/2015 - "Our findings suggest that the cardioprotective effects of YT-146 against ischemia/reperfusion injury are at least partially due to the preservation of mitochondrial function in the ischemic myocardium. "
04/01/2006 - "The present study was aimed at determining whether the novel adenosine A2-agonist YT-146 may have cardioprotective effects against ischemia-reperfusion injury. "
01/01/2015 - "These results suggest that preischemic YT-146 treatment preserves the energy-producing ability of mitochondria during ischemia in the Na(+)-accumulated myocardium. "
01/01/2015 - "YT-146 treatment attenuated the Na(+) content of a mitochondria-enriched fraction, but not the myocardial Na(+) content, at the end of ischemia. "
02/01/2011 - "YT-146 was infused for 10 minutes just before ischemia, and selective antagonists for AR subtypes were coadministered with YT-146. "
04/01/2006 - "Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146)."
09/01/2000 - "To examine whether adenosine reduces ischemia/reperfusion (I/R)-induced liver injury by inhibiting leukocyte activation via A(2) receptor (A(2)R) stimulation, we investigated the effects of adenosine and selective A(2A) receptor (A(2A)R) agonists (YT-146 and CGS21680C) on I/R-induced liver injury in rats. "